Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Breast 2Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 279Triple Negative Breast Neoplasms 146Neoplasm Metastasis 27Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Inflammatory Breast Neoplasms 15Pancreatic Neoplasms 12Neoplasms 11Endometrial Neoplasms 11Breast Neoplasms, Male 11Colorectal Neoplasms 8Carcinoma, Ductal, Breast 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lung Neoplasms 7Prostatic Neoplasms 6Melanoma 6Fallopian Tube Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pathologic Complete Response 5HER2-positive Breast Cancer 5Carcinoma, Ovarian Epithelial 5Esophageal Neoplasms 4Carcinoma, Lobular 4Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Multiple Myeloma 3

Interventions

olaparib 4Carboplatin 2talazoparib 1pembrolizumab 1Surveys and Questionnaires 1Paclitaxel 1Genotype 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Carboplatin × Breast × Clear all
NCT05485766 2025-03-20

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Okayama University

Phase 2 Recruiting
23 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02418624 2019-01-16

REVIVAL

The Netherlands Cancer Institute

Phase 1 Completed
25 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡